Roledumab
Monoclonal antibody
N
Y (what is this?) (verify) Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1][2]
It is currently at Phase III trials for Rh disease.
References
- ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
- ^ Kaplon H, Reichert JM (2018). "Antibodies to watch in 2018". mAbs. 10 (2): 183–203. doi:10.1080/19420862.2018.1415671. PMC 5825203. PMID 29300693.
- v
- t
- e
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
